首页> 外国专利> 6 134- 134-Oxadiazole Amide Derivative Compounds as Histone Deacetylase 6 Inhibitor and the Pharmaceutical Composition Comprising the same

6 134- 134-Oxadiazole Amide Derivative Compounds as Histone Deacetylase 6 Inhibitor and the Pharmaceutical Composition Comprising the same

机译:组蛋白脱乙酰基酶6抑制剂的6 134-134-恶二唑酰胺衍生物及其组成的药物组合物

摘要

The present invention relates to a novel compound having the activity of inhibiting histone deacetylase 6 (HDAC6), an optical isomer thereof or a pharmaceutically acceptable salt thereof, a use thereof for the production of a therapeutic drug, a pharmaceutical composition containing the same And a method of treating the same, and a method for producing the same. The novel compounds, their optical isomers or pharmaceutically acceptable salts thereof according to the present invention have the activity of inhibiting histone deacetylase 6 (HDAC6) and are useful in the treatment of infectious diseases, neoplasm, endocrine, Related diseases including diseases, mental and behavioral disorders, neurological diseases, eye and appendage diseases, circulatory diseases, respiratory diseases, gastrointestinal diseases, skin and subcutaneous tissue disorders, musculoskeletal and connective tissue disorders or congenital malformations, It is effective for prevention or treatment.
机译:本发明涉及具有抑制组蛋白脱乙酰基酶6(HDAC6)活性的新型化合物,其旋光异构体或其药学上可接受的盐,其在制备治疗药物中的用途,含有该化合物的药物组合物和处理方法及其制造方法。根据本发明的新型化合物,其旋光异构体或其药学上可接受的盐具有抑制组蛋白脱乙酰基酶6(HDAC6)的活性,可用于治疗传染病,肿瘤,内分泌,相关疾病,包括疾病,精神病和行为疾病,神经系统疾病,眼及阑尾疾病,循环系统疾病,呼吸系统疾病,胃肠道疾病,皮肤和皮下组织疾病,肌肉骨骼和结缔组织疾病或先天性畸形,对预防或治疗有效。

著录项

  • 公开/公告号KR101799009B1

    专利类型

  • 公开/公告日2017-11-17

    原文格式PDF

  • 申请/专利权人 주식회사 종근당;

    申请/专利号KR20160095334

  • 发明设计人 이재광;고무성;한영휘;김윤태;

    申请日2016-07-27

  • 分类号C07D271/10;A61K31/4245;C07D413/10;C07D413/12;

  • 国家 KR

  • 入库时间 2022-08-21 12:41:36

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号